Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-12-09
2000-05-16
Saunders, David
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530350, 530848, C07K 14435, A61K 3817
Patent
active
060637676
ABSTRACT:
The invention provides two human phospholipid binding proteins (PLBP) and polynucleotides which identify and encode PLBP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of PLBP.
REFERENCES:
patent: 5225537 (1993-07-01), Foster
patent: 5658877 (1997-08-01), Tsao
Wirtz, K.W.A., "Phospholipid Transfer Proteins", Annu. Rev. Biochem., 60: 73-99 (1991).
Geijtenbeek, T.B.H. et al., "cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene", Biochem. J., 316: 49-55 (1996) (GI 897693).
Teerlink, T. et al., "Tissue Distribution And Subcellular Localization Of Phosphatidylcholine Transfer Protein In Rats As Determined By Radioimmunoassay", Biochim. Biophys. Acta, 713: 61-67 (1982).
Smit, J.J.M. et al., "Homozygous Disruption of the Murine mdr2 P-Glycoprotein Gene Leads to a Complete Absence of Phospholipid from Bile and to Liver Disease", Cell, 75: 451-462 (1993).
Exton, J.H., "Phosphatidylcholine breakdown and signal transduction", Biochim. Biophys. Acta, 1212: 26-42 (1994).
Hristova, K. et al., "Critical Role of Lipid Composition in Membrane Permeabilization by Rabbit Neutrophil Defensins", J. Biol. Chem., 272: 24224-24233 (1997).
Pavlinova, L.I. et al., "Role Of The Phosphoinositide Signal System And Methylation Of Phosphatidylethanolamine In The Development Of Long-Term Post-Tetanic Potentiation In Rats", Neurosci. Behav. Physiol. 27: 234-239 (1997).
James, P.F. and R.A. Zoeller, "Isolation of Animal Cell Mutants Defective in Long-chain Fatty Aldehyde Dehydrogenase", J. Biol. Chem., 272: 23532-23529 (1997).
Hori, N. et al., "A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein", Gene, 140: 293-294 (1994).
Seddiqi, N. et al., "Characterization and localization of the rat, mouse and human testicular phosphatidylethanolamine binding protein", Experimentia, 52: 101-110 (1996).
Erttmann, K.D. et al., "Onchocerca volvulus: identification of cDNAs encoding a putative phosphatidyl-ethanolamine-binding protein and a putative partially processed mRNA precursor", Gene, 174: 203-207 (1996).
Erttmann, K.D. et al., (Direct Submission), GenBank Sequence Database (Accession X87991), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894 (GI 1143526; GI 1143527).
van Paridon, P.A. et al., "Properties of the Binding Sites for the sn-1 and sn-2 Acyl Chains on the Phosphatidylinositol Transfer Protein from Bovine Brain", Biochemistry, 27: 6208-6214 (1988).
Corley Neil C.
Hillman Jennifer L.
Lal Preeti
Shah Purvi
Incyte Pharmaceuticals Inc.
Saunders David
Tung Mary Beth
LandOfFree
Human phospholipid binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human phospholipid binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human phospholipid binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-259001